Details for New Drug Application (NDA): 021540
✉ Email this page to a colleague
NDA 021540 describes CADUET, which is a drug marketed by Pharmacia and is included in one NDA. It is available from two suppliers. Additional details are available on the CADUET profile page.
The generic ingredient in CADUET is amlodipine besylate; atorvastatin calcium. There are fifty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the amlodipine besylate; atorvastatin calcium profile page.
The generic ingredient in CADUET is amlodipine besylate; atorvastatin calcium. There are fifty drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the amlodipine besylate; atorvastatin calcium profile page.
Summary for 021540
| Tradename: | CADUET |
| Applicant: | Pharmacia |
| Ingredient: | amlodipine besylate; atorvastatin calcium |
| Patents: | 0 |
Suppliers and Packaging for NDA: 021540
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-2260 | 0069-2260-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0069-2260-30) |
| CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540 | NDA | Pfizer Laboratories Div Pfizer Inc | 0069-6180 | 0069-6180-30 | 30 TABLET, FILM COATED in 1 BOTTLE (0069-6180-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;EQ 10MG BASE | ||||
| Approval Date: | Jan 30, 2004 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;EQ 20MG BASE | ||||
| Approval Date: | Jan 30, 2004 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;EQ 40MG BASE | ||||
| Approval Date: | Jan 30, 2004 | TE: | AB | RLD: | Yes | ||||
Expired US Patents for NDA 021540
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-006 | Jan 30, 2004 | ⤷ Subscribe | ⤷ Subscribe |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-008 | Jan 30, 2004 | ⤷ Subscribe | ⤷ Subscribe |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-002 | Jan 30, 2004 | ⤷ Subscribe | ⤷ Subscribe |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-011 | Jul 29, 2004 | ⤷ Subscribe | ⤷ Subscribe |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-008 | Jan 30, 2004 | ⤷ Subscribe | ⤷ Subscribe |
| Pharmacia | CADUET | amlodipine besylate; atorvastatin calcium | TABLET;ORAL | 021540-002 | Jan 30, 2004 | ⤷ Subscribe | ⤷ Subscribe |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
